Literature DB >> 24900243

Design, Synthesis, and in Vitro Evaluation of Novel Aminomethyl-pyridines as DPP-4 Inhibitors.

Katarzyna Kaczanowska1, Karl-Heinz Wiesmüller1, Arnaud-Pierre Schaffner1.   

Abstract

A collection of novel aminomethyl-pyridines was designed, synthesized, and investigated as potential inhibitors of DPP-4. Optimization of the screening hit afforded a number of 5-aminomethyl-pyridines with inhibitory activity in the nanomolar range. Selected DPP-4 inhibitors were further evaluated for their selectivity over the closely related peptidase DPP-8. 5-Aminomethyl-4-(2,4-dichloro-phenyl)-6-methyl-pyridine-2-carboxylic acid cyanomethyl-amide showed high potency and excellent DPP-4 selectivity [IC50: 10 (DPP-4) and 6600 nM (DPP-8)] and no toxicity in mammalian cell culture.

Entities:  

Keywords:  Aminomethyl-pyridines; DPP-4; DPP-8; diabetes; incretins; structure−activity relationship

Year:  2010        PMID: 24900243      PMCID: PMC4007959          DOI: 10.1021/ml100200c

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  25 in total

1.  Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.

Authors:  Kent W Christopherson; Giao Hangoc; Hal E Broxmeyer
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

Review 2.  Incretins: a new treatment option for type 2 diabetes?

Authors:  P H L M Geelhoed-Duijvestijn
Journal:  Neth J Med       Date:  2007-02       Impact factor: 1.422

3.  Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.

Authors:  C Durinx; A M Lambeir; E Bosmans; J B Falmagne; R Berghmans; A Haemers; S Scharpé; I De Meester
Journal:  Eur J Biochem       Date:  2000-09

Review 4.  Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Authors:  Nancy A Thornberry; Ann E Weber
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 5.  Molecular recognition of ligands in dipeptidyl peptidase IV.

Authors:  Bernd Kuhn; Michael Hennig; Patrizio Mattei
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 6.  Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.

Authors:  Pieter Van der Veken; Achiel Haemers; Koen Augustyns
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 7.  Dipeptidyl peptidase IV inhibitors: the next generation of new promising therapies for the management of type 2 diabetes.

Authors:  Elena Sebokova; Andreas D Christ; Markus Boehringer; Jacques Mizrahi
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 8.  Incretin-based therapies in type 2 diabetes mellitus.

Authors:  Chee W Chia; Josephine M Egan
Journal:  J Clin Endocrinol Metab       Date:  2008-07-15       Impact factor: 5.958

9.  Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites.

Authors:  Susan Lorey; Angela Stöckel-Maschek; Jürgen Faust; Wolfgang Brandt; Beate Stiebitz; Mark D Gorrell; Thilo Kähne; Carmen Mrestani-Klaus; Sabine Wrenger; Dirk Reinhold; Siegfried Ansorge; Klaus Neubert
Journal:  Eur J Biochem       Date:  2003-05

10.  Modulations of the amide function of the preferential dopamine D3 agonist (R,R)-S32504: improvements of affinity and selectivity for D3 versus D2 receptors.

Authors:  Jean-Louis Peglion; Christophe Poitevin; Clotilde Mannoury La Cour; Delphine Dupuis; Mark J Millan
Journal:  Bioorg Med Chem Lett       Date:  2009-03-09       Impact factor: 2.823

View more
  2 in total

1.  Synthesis and Suzuki-Miyaura cross-coupling reactions of potassium Boc-protected aminomethyltrifluoroborate with aryl and hetaryl halides.

Authors:  Gary A Molander; Inji Shin
Journal:  Org Lett       Date:  2011-07-06       Impact factor: 6.005

2.  Suzuki-Miyaura cross-coupling reactions of potassium Boc-protected aminomethyltrifluoroborate with aryl and hetaryl mesylates.

Authors:  Gary A Molander; Inji Shin
Journal:  Org Lett       Date:  2012-05-31       Impact factor: 6.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.